Jennifer Pevec’s journey has mapped onto a remarkable period of explosive progress in the MS landscape, which has seen ...

Hundreds of people gathered at James Island County Park to participate in a Walk MS event, fundraising for research and ...

A new treatment option for people with multiple sclerosis could alleviate resource strains on New Zealand's health system.

The 11th annual fundraiser is set for May 14 to bring together members of the MS community and raise support for programs and ...

Brian Compton, the managing editor/days at NHL.com was diagnosed with multiple sclerosis. It was stunning news for Brian, who ...

Burdened by competitive pressures for its stalwart multiple sclerosis franchise, Biogen has weathered years of sales declines ...

According to CEO Daniel Vitt, clinical and disability-related outcomes are more relevant than brain volume change for drug ...

The National Multiple Sclerosis Society has committed $18.1 million in multi-year funding to support research projects aligned with its Pathways to Cures roadmap that focuses on three critical areas: ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

Immunic’s lead oral small molecule has failed to hit the primary endpoint of a phase 2 trial in patients with progressive ...

More than one million people in the United States live with Multiple Sclerosis (MS), a chronic neurological disease that ...

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...